No products
View larger AOB18696
CAS: 2762619-63-4
Chemical Name: 1-[1-(2-Fluoroprop-2-enoyl)azetidin-3-yl]-3-[4-(trifluoromethyl)phenyl]imidazo[4,5-b]pyrazin-2-one
1000 Items
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $26.35 | Total: $131.75 |
| 1 | 10 | $22.32 | Total: $223.20 |
| 1 | 25 | $18.91 | Total: $472.75 |
| 1 | 50 | $16.12 | Total: $806.00 |
| 1 | 100 | $13.95 | Total: $1,395.00 |
| Molecular Formula | C18H13F4N5O2 |
| Molecular Weight | 407.33 |
| CAS Numbers | 2762619-63-4 |
| Storage Condition | 0C Short Term, -20C Long Term |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| Synonym | BPI-460372; BPI 460372; BPI460372 |
| IUPAC/Chemical Name | 1-(1-(2-fluoroacryloyl)azetidin-3-yl)-3-(4-(trifluoromethyl)phenyl)-1,3-dihydro-2H-imidazo[4,5-b]pyrazin-2-one |
| InChl Key | SODJZYMRWMUOMC-UHFFFAOYSA-N |
| InChl Code | InChI=1S/C18H13F4N5O2/c1-10(19)16(28)25-8-13(9-25)27-15-14(23-6-7-24-15)26(17(27)29)12-4-2-11(3-5-12)18(20,21)22/h2-7,13H,1,8-9H2 |
| SMILES Code | O=C1N(C2=CC=C(C(F)(F)F)C=C2)C3=NC=CN=C3N1C4CN(C(C(F)=C)=O)C4 |
| References | 1) Ren J, Liu H, Ma Y, Tian W, Li Q, Wu Z, Wang M, Liu X, Zheng X, Han X. Development and validation of a UPLC-MS/MS method for rapid and simultaneous quantification of BPI-460372 and its metabolites BPI-460444 and BPI-460456 in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2024 Oct 15;1247:124300. doi: 10.1016/j.jchromb.2024.124300. Epub 2024 Sep 8. PMID: 39265487. 2) Liu X, Zhong D, Tang CZ, Xu X, Lan H, Diao X. In vitro and In vivo Drug Metabolism Analysis of BPI-460372 - A Covalent TEAD1/3/4 Inhibitor. Curr Drug Metab. 2025 Feb 11. doi: 10.2174/0113892002351556250123105344. Epub ahead of print. PMID: 39950481. |
Novel covalent TEAD1/3/4 inhibitor for the treatment of cancers with Hippo pathway alterations.